CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 2.59
- -0.10-3.72%
Noon Break Sep 18 11:30 CST
1.58BMarket Cap-60232P/E (TTM)
2.72High2.57Low144.20KlotVolume2.69Open2.69Pre Close37.97MTurnover2.37%Turnover RatioLossP/E (Static)609.18MShares5.2852wk High3.52P/B1.58BFloat Cap2.2152wk Low2.96Limit Up609.18MShs Float22.10Historical High2.42Limit Down5.58%Amplitude2.21Historical Low--Dividend TTM2.63Avg Price86.70KlotAsk--Div YieldTTM100Lot Size56.70KlotBid
Zhejiang Yatai Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -3.45%686.35M | -10.27%663.14M | -4.90%720.47M | -3.68%705.49M | 0.17%710.87M | -7.47%739M | -7.73%757.62M | -13.91%732.46M | -12.67%709.63M | -15.36%798.69M |
| Notes receivable and accounts receivable | -25.76%74.66M | -22.97%72.36M | -10.72%79.51M | 35.89%102.78M | 26.39%100.56M | 60.29%93.93M | 27.29%89.06M | 3.14%75.64M | -1.09%79.56M | -41.04%58.6M |
| -Accounts receivable | -25.76%74.66M | -22.97%72.36M | -10.72%79.51M | 35.89%102.78M | 26.39%100.56M | 60.29%93.93M | 27.29%89.06M | 3.14%75.64M | -1.09%79.56M | -41.04%58.6M |
| Other receivables (including interest and dividends) | 76.69%29.88M | 5.23%15.52M | 2.54%15.52M | 1,294.60%16.77M | 1,447.54%16.91M | 1,187.85%14.75M | 1,179.53%15.14M | -97.13%1.2M | -98.58%1.09M | -98.52%1.15M |
| -Other receivable | 76.69%29.88M | ---- | 2.54%15.52M | ---- | 1,447.54%16.91M | ---- | 1,179.53%15.14M | ---- | -98.58%1.09M | ---- |
| Advance payment | -30.28%1.46M | 18.74%3.17M | 19.06%4.24M | -79.70%5.06M | -32.13%2.09M | -15.56%2.67M | 11.72%3.56M | 304.98%24.91M | -12.42%3.08M | -71.82%3.16M |
| Inventories | 0.73%81.52M | -1.82%91.61M | -6.02%89.47M | -11.61%74.38M | 36.46%80.93M | 36.15%93.32M | 56.33%95.2M | 63.44%84.15M | -7.02%59.31M | -26.47%68.54M |
| Receivable financing | 120.63%26.33M | 105.29%39.11M | 21.41%32.29M | -36.40%9.28M | -17.15%11.93M | 104.37%19.05M | 74.09%26.6M | 36.68%14.59M | 85.93%14.4M | -24.97%9.32M |
| Other current assets | -22.32%11.65M | -21.02%12.32M | -22.65%13.67M | -21.80%14.44M | -25.98%15M | -33.08%15.59M | -27.06%17.67M | -28.93%18.47M | -23.47%20.26M | -15.32%23.3M |
| Total current assets | -2.82%911.84M | -8.29%897.22M | -4.94%955.18M | -2.44%928.21M | 5.74%938.29M | 1.62%978.31M | 0.90%1B | -10.27%951.42M | -17.18%887.33M | -23.89%962.75M |
| Non Current assets | ||||||||||
| Other non-current financial assets | -6.85%34.99M | -18.03%36.36M | -7.84%37.75M | -3.34%39.77M | -20.22%37.56M | -15.20%44.35M | -29.70%40.96M | -23.47%41.14M | -34.80%47.07M | 25.58%52.3M |
| Investment real estate | -94.75%628.42K | -94.76%637.18K | -94.76%645.94K | --11.8M | --11.98M | --12.16M | --12.33M | ---- | ---- | ---- |
| Fixed assets | -5.09%350.85M | ---- | -5.13%364.75M | ---- | -10.32%369.67M | ---- | -10.69%384.5M | ---- | -2.87%412.19M | ---- |
| Constru in process | 91.23%798.89K | ---- | --33.63K | ---- | -61.67%417.77K | ---- | --0 | ---- | -97.79%1.09M | ---- |
| Intangible assets | -7.30%56.34M | -0.53%57.77M | 3.47%59.21M | 19.39%59.36M | 20.75%60.78M | 14.00%58.08M | 10.95%57.22M | -1.19%49.71M | 2.54%50.33M | 2.90%50.95M |
| Development expenditure | -4.67%13M | -28.68%12.56M | -43.26%11.13M | -79.88%13.63M | -79.70%13.63M | -73.78%17.61M | -70.75%19.62M | -5.51%67.76M | -5.58%67.16M | -2.59%67.16M |
| Long deferred expense | -3.52%301.32K | -82.64%351.54K | -90.78%232.52K | -90.88%272.42K | -89.87%312.32K | -42.89%2.03M | -37.10%2.52M | -33.21%2.99M | -37.50%3.08M | -34.29%3.55M |
| Deferred tax assets | ---- | ---- | ---- | ---- | ---- | ---- | --254.95K | ---- | ---- | ---- |
| Usufruct assets | ---- | ---- | ---- | ---- | ---- | -47.83%1.19M | -46.15%1.39M | --1.69M | --1.99M | --2.28M |
| Other non current assets | ---- | ---- | 92.27%436.33K | ---- | ---- | ---- | --226.93K | ---- | ---- | ---- |
| Total non current assets | -7.57%456.9M | -9.26%465.41M | -8.64%474.19M | -14.31%488.12M | -15.19%494.35M | -14.34%512.91M | -15.60%519.03M | -16.28%569.62M | -17.24%582.92M | -12.16%598.79M |
| Total assets | -4.46%1.37B | -8.62%1.36B | -6.20%1.43B | -6.88%1.42B | -2.56%1.43B | -4.50%1.49B | -5.40%1.52B | -12.62%1.52B | -17.20%1.47B | -19.78%1.56B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | -0.00%50.06M | -37.43%50.05M | 66.85%50.05M | --50.09M | --50.06M | --80M | --30M | ---- |
| Notes payable and accounts payable | -6.29%44.18M | -42.65%51.42M | -42.34%51.8M | -8.86%45.25M | 16.02%47.15M | 134.11%89.65M | 66.58%89.83M | 37.33%49.64M | 20.93%40.64M | -34.30%38.29M |
| -Notes payable | ---- | ---- | -92.36%2.32M | --10.07M | --7.75M | --30.37M | --30.37M | ---- | ---- | ---- |
| -Accounts payable | 12.16%44.18M | -13.26%51.42M | -16.79%49.48M | -29.15%35.17M | -3.06%39.39M | 54.80%59.28M | 10.27%59.46M | 37.33%49.64M | 20.93%40.64M | -34.30%38.29M |
| Contract liabilities | -11.91%2.4M | 243.17%7.25M | -41.28%7.89M | -9.75%2.59M | 15.31%2.72M | -2.87%2.11M | 386.20%13.44M | 39.97%2.87M | 27.48%2.36M | -2.34%2.17M |
| Advance receipts | -92.09%27.52K | -93.01%48.17K | -93.32%68.81K | --113.67K | --347.89K | --688.9K | --1.03M | ---- | ---- | ---- |
| Salaries payable | 14.34%8.49M | 11.05%8.22M | -2.96%11.73M | -17.18%7.07M | -0.81%7.42M | -12.86%7.4M | -12.93%12.09M | -16.17%8.54M | -19.28%7.48M | 1.40%8.49M |
| Taxs payable | -17.34%3.94M | -65.66%1.34M | -49.58%5.46M | -72.90%2.31M | -48.51%4.77M | -56.27%3.9M | 35.68%10.83M | 67.35%8.52M | 116.35%9.27M | 22.22%8.93M |
| Other payable (including interest and dividends) | -24.06%30.64M | -16.07%32.28M | -18.93%33.77M | 14.15%36.2M | 85.56%40.35M | 65.10%38.46M | 75.43%41.65M | 18.96%31.71M | -10.97%21.75M | -82.60%23.29M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --90.77K | --32.63K | ---- |
| -Other payable | -24.06%30.64M | ---- | -18.93%33.77M | ---- | 85.84%40.35M | ---- | 75.43%41.65M | ---- | -11.10%21.71M | ---- |
| Non current liabilities due within one year | --645.56M | ---- | ---- | ---- | ---- | -98.47%1.71M | -98.48%1.7M | -99.18%1.35M | -99.18%1.35M | 32.56%111.51M |
| Other current liabilities | -11.91%311.48K | 243.17%941.99K | -41.28%1.03M | -9.75%336.35K | 16.80%353.58K | 7.94%274.5K | 412.32%1.75M | 50.57%372.7K | 36.74%302.73K | -6.13%254.31K |
| Total current liabilities | 380.23%735.56M | -47.76%101.49M | -27.24%161.8M | -21.36%143.91M | 35.38%153.17M | 0.69%194.28M | 3.84%222.38M | -25.03%183M | -52.33%113.14M | -34.47%192.95M |
| Current liabilities | ||||||||||
| Bonds payable | ---- | -29.13%636.53M | -28.95%639.48M | -8.57%811.49M | 4.06%910.89M | 4.05%898.15M | 4.46%900.01M | 4.46%887.6M | 4.46%875.33M | 3.85%863.19M |
| Estimate liabilities | 0.00%38.04M | -57.65%38.04M | -57.65%38.04M | -52.23%38.04M | -52.23%38.04M | 12.79%89.83M | 12.79%89.83M | 32.95%79.65M | 32.95%79.65M | 32.95%79.65M |
| Deferred tax liabilities | -4.58%3.2M | -11.70%3.4M | 1.64%3.61M | 15.02%3.88M | -21.39%3.35M | -23.63%3.85M | -40.20%3.55M | -35.97%3.37M | -46.94%4.26M | 59.60%5.05M |
| Long term deferred income | -19.93%4.96M | -19.21%5.26M | -18.47%5.56M | -58.65%5.88M | -57.38%6.2M | -56.16%6.51M | -54.99%6.83M | -9.45%14.22M | -4.80%14.53M | 38.68%14.85M |
| Lease liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --669.22K | --1.39M | --960.37K |
| Total non current liabilities | -95.18%46.2M | -31.56%683.24M | -31.35%686.7M | -12.81%859.3M | -1.71%958.48M | 3.60%998.34M | 3.79%1B | 5.90%985.51M | 5.86%975.17M | -5.07%963.69M |
| Total liabilities | -29.68%781.76M | -34.20%784.73M | -30.60%848.5M | -14.15%1B | 2.14%1.11B | 3.11%1.19B | 3.80%1.22B | -0.52%1.17B | -6.06%1.09B | -11.68%1.16B |
| Shareholders equity | ||||||||||
| Paid-in capital | 13.51%609.18M | 13.51%609.18M | 13.51%609.17M | 5.17%564.44M | 0.00%536.69M | 0.00%536.69M | 0.01%536.69M | 0.01%536.68M | 0.01%536.68M | 0.01%536.67M |
| Other equity instruments | -31.73%139.39M | -31.73%139.39M | -31.73%139.4M | -12.15%179.37M | -0.01%204.17M | -0.02%204.17M | -0.11%204.17M | -0.12%204.18M | -0.12%204.19M | -0.12%204.21M |
| Capital reserve funds | 21.66%1.59B | 21.66%1.59B | 21.66%1.59B | 8.22%1.42B | 0.01%1.31B | 0.01%1.31B | 0.09%1.31B | 0.09%1.31B | 0.09%1.31B | 0.09%1.31B |
| Surplus reserve funds | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M | 0.00%60.56M |
| Retained profit | -1.46%-1.82B | -0.67%-1.82B | -0.66%-1.82B | -2.85%-1.81B | -3.53%-1.79B | -6.24%-1.81B | -7.91%-1.81B | -13.90%-1.76B | -15.83%-1.73B | -15.84%-1.71B |
| Other composite income | ---- | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K | 0.00%-598.38K |
| Shareholders equity without minority interests | 82.87%586.98M | 93.54%577.91M | 92.81%580.87M | 17.19%413.13M | -15.96%320.99M | -26.25%298.6M | -30.42%301.27M | -37.72%352.53M | -38.12%381.94M | -36.44%404.91M |
| Total shareholder equity | 82.87%586.98M | 93.54%577.91M | 92.81%580.87M | 17.19%413.13M | -15.96%320.99M | -26.25%298.6M | -30.42%301.27M | -37.72%352.53M | -38.12%381.94M | -36.44%404.91M |
| Total liabilityies and equity | -4.46%1.37B | -8.62%1.36B | -6.20%1.43B | -6.88%1.42B | -2.56%1.43B | -4.50%1.49B | -5.40%1.52B | -12.62%1.52B | -17.20%1.47B | -19.78%1.56B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | ZTE Finance Guanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | ZTE Finance Guanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data